Introduction Retro Biosciences, a pioneering biotech company, has embarked on an ambitious journey to extend human lifespan by a decade through innovative approaches to combat cellular aging. Its strategic partnership with Multiply Labs, a firm celebrated for advanced automation and robotic
The relentless progress of medical technology regularly unlocks new arenas in the battle against disease, with one of the most notable being the potent capabilities of Natural Killer (NK) cell therapies. As critical members of the immune system, NK cells have become the cornerstone of an innovative
In the dynamic realm of biopharmaceutical investments, the diverging analyst ratings for Can-Fite BioPharma (NYSE: CANF) underscore the complex calculus of betting on drug development firms. The stock analysis firm StockNews.com has planted its flag with a "hold" rating, signaling a
The lab automation market is a rapidly growing field, expected to reach a staggering $11.31 billion by 2031. This growth is driven by several factors, including increased R&D spending, the rising prevalence of chronic and infectious diseases, higher demand for lab automation, and significant
In the bustling bio-cluster of Genome Valley, Hyderabad, sits a new beacon of innovation: Aurigene Pharmaceutical Services' sprawling 70,000-square-foot biologics facility. This strategic extension, an affiliate of Dr. Reddy’s Laboratories, heralds a new era for biopharmaceutical development a
Multiple myeloma (MM), a cancer that attacks the plasma cells in bone marrow, often evades cure, pushing scientists to constantly search for breakthrough therapies. Chimeric Antigen Receptor (CAR) T cell therapy represents one of the most innovative and promising strategies against relapsed MM. Its
